Fasting plasma glucose in screening for diabetes in the Taiwanese population. 1998

C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China. jins@mail.ncku.edu.tw

OBJECTIVE To reveal the relationship between fasting and 2-h postload plasma glucose and to examine the appropriate fasting glucose cutoff as the primary screening test for diabetes. METHODS We recruited 5,303 subjects from preventive services of the National Cheng Kung University Hospital. Exclusion criteria were age <20 years, pregnancy, known diabetes, and a history of recent surgery, trauma, or illness. All subjects received the 75-g oral glucose tolerance test. The relationship between fasting and 2-h glucose was examined. Sensitivities, specificities, efficiency, and predictive values were assessed at different cutoffs of fasting glucose for prediction of diabetes. RESULTS The best fit model for the relationship between fasting and 2-h glucose was fasting glucose = 4.914-0.060 x (2-h glucose) + 0.0144 x (2-h glucose)2. From this model, the fasting glucose was 6.0 mmol/l when 2-h glucose was 11.1 mmol/l. A fasting glucose with 6.25 mmol/l gave the same diabetes prevalence as the World Health Organization 2-h glucose criterion. When 7.8 mmol/l was the fasting glucose cutoff, the sensitivity was 28.5%. Lowering the cutoff from 7.8 to 7.0 mmol/l increased the sensitivity by 11.2% and slightly reduced the specificity and positive predictive value. If the cutoffs were 6.25 and 6.0 mmol/l, the sensitivity increased and the specificity and the positive predictive value decreased accordingly. CONCLUSIONS Our results suggest that fasting glucose as a screening criterion for diabetes could be revised downward to 7.0 mmol/l, because the slight reduction of positive predictive value was more than balanced by an apparent increase of sensitivity and insignificant change of specificity.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
June 2015, Metabolic syndrome and related disorders,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
February 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
July 2016, World journal of diabetes,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
August 1997, Diabetic medicine : a journal of the British Diabetic Association,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
August 2003, Journal for scientific research. Medical sciences,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
December 2015, Chinese medical journal,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
June 2019, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
February 2007, Archives of gynecology and obstetrics,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
October 2000, Diabetic medicine : a journal of the British Diabetic Association,
C J Chang, and J S Wu, and F H Lu, and H L Lee, and Y C Yang, and M J Wen
September 2008, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!